Nicotinic acetylcholine receptor signaling maintains epithelial barrier integrity

Abstract

Disruption of epithelial barriers is a common disease manifestation in chronic degenerative diseases of the airways, lung and intestine. Extensive human genetic studies have identified risk loci in such diseases, including in chronic obstructive pulmonary disease (COPD) and inflammatory bowel diseases (IBD). The genes associated with these loci have not fully been determined, and functional characterization of such genes requires extensive studies in model organisms. Here, we report the results of a screen in Drosophila melanogaster that allowed for rapid identification, validation and prioritization of COPD risk genes that were selected based on risk loci identified in human genome-wide association studies (GWAS) studies. Using intestinal barrier dysfunction in flies as a readout, our results validate the impact of candidate gene perturbations on epithelial barrier function in 56% of the cases, resulting in a prioritized target gene list. We further report the functional characterization in flies of one family of these genes, encoding for nicotinic acetylcholine receptor subunits (nAchR). We find that nAchR signaling in enterocytes of the fly gut promotes epithelial barrier function and epithelial homeostasis by regulating the production of the peritrophic matrix. Our findings identify COPD associated genes critical for epithelial barrier maintenance, and provide insight into the role of epithelial nAchR signaling for homeostasis.

Microbiota-derived acetylcholine can promote gut motility in Drosophila melanogaster

“…Acetylcholine is well known as a primary neurotransmitter in the central nervous system, but reports have also shown that peripheral acetylcholine plays an important role including in regulation of immunity [33] and gut barrier homeostasis [34]. Since acetylcholine promotes gut motility in mammals [35] and potentially in Drosophila [16], we hypothesized that acetylcholine mediates the effect of L.p culture supernatant on GI motility.…”